Triple

T9524764
Position Surface form Disambiguated ID Type / Status
Subject levodopa E229731 entity
Predicate oftenCombinedWith P4791 FINISHED
Object carbidopa
Carbidopa is a medication used in combination with levodopa to treat Parkinson’s disease by preventing peripheral breakdown of levodopa and reducing its side effects.
 E804842 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: carbidopa | Statement: [levodopa, oftenCombinedWith, carbidopa]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: carbidopa
Context triple: [levodopa, oftenCombinedWith, carbidopa]
  • A. levodopa
    Levodopa is a cornerstone medication for managing Parkinson’s disease symptoms by replenishing the brain’s depleted dopamine levels.
  • B. entacapone
    Entacapone is a catechol-O-methyltransferase (COMT) inhibitor used as an adjunct medication in Parkinson’s disease therapy to prolong and enhance the effects of levodopa.
  • C. rivastigmine
    Rivastigmine is a cholinesterase inhibitor medication used to manage symptoms of mild to moderate dementia, particularly in Alzheimer's and Parkinson's disease.
  • D. pimozide
    Pimozide is a typical antipsychotic medication primarily used to treat Tourette’s disorder and severe tics.
  • E. Namenda
    Namenda is a prescription medication used to treat moderate to severe Alzheimer's disease by regulating the activity of glutamate in the brain.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: carbidopa
Triple: [levodopa, oftenCombinedWith, carbidopa]
Generated description
Carbidopa is a medication used in combination with levodopa to treat Parkinson’s disease by preventing peripheral breakdown of levodopa and reducing its side effects.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: carbidopa
Target entity description: Carbidopa is a medication used in combination with levodopa to treat Parkinson’s disease by preventing peripheral breakdown of levodopa and reducing its side effects.
  • A. levodopa
    Levodopa is a cornerstone medication for managing Parkinson’s disease symptoms by replenishing the brain’s depleted dopamine levels.
  • B. entacapone
    Entacapone is a catechol-O-methyltransferase (COMT) inhibitor used as an adjunct medication in Parkinson’s disease therapy to prolong and enhance the effects of levodopa.
  • C. rivastigmine
    Rivastigmine is a cholinesterase inhibitor medication used to manage symptoms of mild to moderate dementia, particularly in Alzheimer's and Parkinson's disease.
  • D. pimozide
    Pimozide is a typical antipsychotic medication primarily used to treat Tourette’s disorder and severe tics.
  • E. Namenda
    Namenda is a prescription medication used to treat moderate to severe Alzheimer's disease by regulating the activity of glutamate in the brain.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69ca847870a881909d8d751a7d29da39 completed March 30, 2026, 2:11 p.m.
NER Named-entity recognition batch_69cd9899f99481908d374528716027f8 completed April 1, 2026, 10:13 p.m.
NED1 Entity disambiguation (via context triple) batch_69d14c1f10748190a36d2092d593be97 completed April 4, 2026, 5:36 p.m.
NEDg Description generation batch_69d14cbfcbbc8190b6601a99dc773cb3 completed April 4, 2026, 5:39 p.m.
NED2 Entity disambiguation (via description) batch_69d14d29d32c8190a8615b3450492abc completed April 4, 2026, 5:40 p.m.
Created at: March 30, 2026, 7:59 p.m.